(Luitpold) Adequan Canine is administered by intramuscular injection for the control of signs associated with non-infectious degenerative and/or traumatic arthritis of canine synovial joints. Adequan Canine contains polysulfated glycosaminoglycan (PSGAG). Polysulfated glycosaminoglycan is characterized as a "disease modifying osteoarthritis drug." Adequan Canine contains 100 mg/ml of polysulfated glycosaminoglycan . The recommended dose of Adequan Canine is 2 mg/lb body weight (.02 mL/lb), by intramuscular injection only, twice weekly for up to 4 weeks. Polysulfated glycosaminoglycan.
Press Release from Luitpold
Please note: During cold weather, this product will be shipped by ground only the first of the week, so that it arrives by Friday. If you need it sooner, please upgrade to 2-day or next day air, or call the pharmacy to arrange the shipping time.